Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement

Stock Information for Werewolf Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Werewolf Therapeutics Inc.

Halper Sadeh LLC is Investigating Whether HOWL, BZH, MKTX, CBZ are Obtaining Fair Deals for their Shareholders
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq - HOWL), Beazer Homes USA, Inc. (NYSE - BZH), MarketAxess Holdings Inc. (Nasdaq - MKTX), CBIZ, Inc. (NYSE - CBZ)
HOWL Stock Alert: Halper Sadeh LLC is Investigating Whether Werewolf Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - HOWL, HZO, TYFG and FULC
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.